TENET HEALTHCARE CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $21.3B | $20.7B | $20.6B | $19.2B | $19.5B |
| Operating income | $3.5B | $6.0B | $2.5B | $2.3B | $2.9B |
| Interest expense | $821.0M | $826.0M | $901.0M | $890.0M | $923.0M |
| Pretax income | $2.8B | $5.2B | $1.6B | $1.3B | $1.9B |
| Income tax expense | $433.0M | $1.2B | $306.0M | $344.0M | $411.0M |
| Net income | $2.4B | $4.1B | $1.3B | $1.0B | $1.5B |
| Balance Sheet | |||||
| Cash and equivalents | $2.9B | $3.0B | $1.2B | $858.0M | $2.4B |
| Current assets | $7.8B | $7.7B | $7.2B | $6.0B | $7.1B |
| Total assets | $29.7B | $28.9B | $28.3B | $27.2B | $27.6B |
| Current liabilities | $4.5B | $4.3B | $4.8B | $4.5B | $5.1B |
| Total liabilities | $20.7B | $20.4B | $22.8B | $22.5B | $23.3B |
| Total debt | $13.2B | $13.2B | $15.0B | $15.1B | $15.6B |
| Stockholders' equity | $4.2B | $4.2B | $1.6B | $1.1B | $1.0B |
| Cash Flow Statement | |||||
| Cash from operations | $3.5B | $2.0B | $2.4B | $1.1B | $1.6B |
| Depreciation and amortization | $863.0M | $818.0M | $870.0M | $841.0M | $855.0M |
| Stock-based compensation | $104.0M | $67.0M | $66.0M | $56.0M | $56.0M |
| Capital expenditure | $1.0B | $931.0M | $751.0M | $762.0M | $658.0M |
| Free cash flow | $2.5B | $1.1B | $1.6B | $321.0M | $910.0M |
| Share repurchases | $1.4B | $672.0M | $200.0M | $250.0M | $0 |
| Impairments | $61.0M | $7.0M | $43.0M | $94.0M | $8.0M |
Shares outstanding 86.1M · Free float 96.0%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.